Lorenzo Brualla1, Francisco J Zaragoza2, Wolfgang Sauerwein1. 1. NCTeam, Strahlenklinik, Universitätsklinikum Essen, Essen, Germany. 2. Institut de Tècniques Energètiques, Universitat Politècnica de Catalunya, Barcelona, Spain.
Abstract
BACKGROUND/AIMS: Ruthenium plaques are used for the treatment of ocular tumors. There is, however, a controversy regarding the maximum treatable tumor height. Some advocate eccentric plaque placement, without a posterior safety margin, to avoid collateral damage to the fovea and optic disc, but this has raised concerns about marginal tumor recurrence. There is a need for quantitative information on the spatial absorbed dose distribution in the tumor and adjacent tissues. We have overcome this obstacle using an approach based on Monte Carlo simulation of radiation transport. METHODS: CCA and CCB (106)Ru plaques were modeled and their geometry embedded in a computerized tomography scan of the eye of a patient. Different tumor sizes and locations were simulated with the general-purpose Monte Carlo code PENELOPE. RESULTS: Cumulative dose-volume histograms were obtained for the tumors and the tissues at risk considered. Plots of isodose lines for both plaques were obtained in a computerized tomography study. CONCLUSIONS: Ruthenium eye plaques are an adequate treatment option for tumors up to around 5 mm in height. According to our results, assuming a correct placement of the plaque, a tumor of 6.5 mm apical height is about the maximum size that can be treated safely with the large CCB plaque.
BACKGROUND/AIMS: Ruthenium plaques are used for the treatment of ocular tumors. There is, however, a controversy regarding the maximum treatable tumor height. Some advocate eccentric plaque placement, without a posterior safety margin, to avoid collateral damage to the fovea and optic disc, but this has raised concerns about marginal tumor recurrence. There is a need for quantitative information on the spatial absorbed dose distribution in the tumor and adjacent tissues. We have overcome this obstacle using an approach based on Monte Carlo simulation of radiation transport. METHODS: CCA and CCB (106)Ru plaques were modeled and their geometry embedded in a computerized tomography scan of the eye of a patient. Different tumor sizes and locations were simulated with the general-purpose Monte Carlo code PENELOPE. RESULTS: Cumulative dose-volume histograms were obtained for the tumors and the tissues at risk considered. Plots of isodose lines for both plaques were obtained in a computerized tomography study. CONCLUSIONS:Ruthenium eye plaques are an adequate treatment option for tumors up to around 5 mm in height. According to our results, assuming a correct placement of the plaque, a tumor of 6.5 mm apical height is about the maximum size that can be treated safely with the large CCB plaque.
Entities:
Keywords:
Beta emitter; Brachytherapy; Dosimetry; Eye plaques; Monte Carlo methods; Ruthenium; Simulation; Treatment planning; Uveal melanoma
Authors: Indrin J Chetty; Bruce Curran; Joanna E Cygler; John J DeMarco; Gary Ezzell; Bruce A Faddegon; Iwan Kawrakow; Paul J Keall; Helen Liu; C M Charlie Ma; D W O Rogers; Jan Seuntjens; Daryoush Sheikh-Bagheri; Jeffrey V Siebers Journal: Med Phys Date: 2007-12 Impact factor: 4.071
Authors: Lorenzo Brualla; Francisco J Zaragoza; Josep Sempau; Andrea Wittig; Wolfgang Sauerwein Journal: Int J Radiat Oncol Biol Phys Date: 2012-01-13 Impact factor: 7.038
Authors: R E Tjho-Heslinga; J Davelaar; H M Kemme; H de Vroome; J A Oosterhuis; J C Bleeker; J W Leer Journal: Radiother Oncol Date: 1999-11 Impact factor: 6.280
Authors: David A Atchison; Catherine E Jones; Katrina L Schmid; Nicola Pritchard; James M Pope; Wendy E Strugnell; Robyn A Riley Journal: Invest Ophthalmol Vis Sci Date: 2004-10 Impact factor: 4.799
Authors: Erik Stöckel; Marion Eichmann; Dirk Flühs; Holger Sommer; Eva Biewald; Norbert Bornfeld; Bernhard Spaan; Wolfgang Sauerwein Journal: Ocul Oncol Pathol Date: 2017-09-16
Authors: Francisco J Zaragoza; Marion Eichmann; Dirk Flühs; Andrea Wittig; Wolfgang Sauerwein; Lorenzo Brualla Journal: Ocul Oncol Pathol Date: 2018-10-15
Authors: Somayeh Asadi; Mehdi Vaez-zadeh; S Farhad Masoudi; Faezeh Rahmani; Courtney Knaup; Ali S Meigooni Journal: J Appl Clin Med Phys Date: 2015-09-08 Impact factor: 2.102